Work

Bevacizumab Use in Patients With Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825

Year: 2015

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2015.07.2257

Authors: W.A. Hall, S.L. Pugh, M.R. Gilbert, J.S. Wefel, T. Armstrong, M.M. Wendland, D.G. Brachman, K.S. Roof, P.D. Brown, I.R. Crocker, H.I. Robins, R.J. Lee, S.T. Chao, L. Kim, G. Srkalovic, B.M. Fisch, M.P. Mehta, W.J. Curran, B. Movsas

Institutions: Medical College of Wisconsin, NRG Oncology, National Institutes of Health, The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center at Houston, Willamette Valley Cancer Institute and Research Center, Arizona Oncology, Southeast Radiation Oncology Group, Emory University, Winship Cancer Institute, University of Wisconsin–Madison, UW Health University Hospital, Intermountain Healthcare, Cleveland Clinic, Thomas Jefferson University, Michigan Cancer Research Consortium, Kaiser Permanente Northern California, University of Maryland, Baltimore, Henry Ford Health

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2608628986

FWCI:

Cites:

Cited by:

Related to: 10